| Literature DB >> 35523530 |
Abstract
Artificial intelligence (AI) for breast imaging has rapidly moved from the experimental to implementation phase. As of this writing, Food and Drug Administration (FDA)-approved mammographic applications are available for triage, lesion detection and classification, and breast density assessment. For sonography and MRI, FDA-approved applications are available for lesion classification. Numerous other interpretive and noninterpretive AI applications are in the development phase. This article reviews AI applications for mammography, sonography, and MRI that are currently available for clinical use. In addition, clinical implementation and the future of AI for breast imaging are discussed.Entities:
Mesh:
Year: 2021 PMID: 35523530 PMCID: PMC9077006 DOI: 10.1053/j.ro.2021.12.005
Source DB: PubMed Journal: Semin Roentgenol ISSN: 0037-198X Impact factor: 0.709